Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 2, 2010, Pages 267-275

  Doblas, Sabrina ^a   He, Ting ^a,b   Saunders, Debbie ^a   Pearson, Jamie ^a   Hoyle, Jessica ^a,c   Smith, Nataliya ^a   Lerner, Megan ^d   Towner, Rheal A ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b Oklahoma Center for Neuroscience   (United States)

^c UNIVERSITY OF OKLAHOMA TULSA   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Glioma; Magnetic resonance angiography; Neovascularization; Peritumoral region

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BLOOD VOLUME; BRAIN TUMOR; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; TUMOR DIAGNOSIS; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344;

EID: 77955365287     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22263     Document Type: Article

References (38)

1. CBTRUS. Statistical report: primary brain tumors in the United States, 2000-2004. Hinsdale, IL: Central brain tumor registry of the United States; 2008. p 1-62.
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
3. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
4. Gudinaviciene I, Pranys D, Juozaityte E. Impact of morphology and biology on the prognosis of patients with gliomas. Medicina (Kaunas) 2004;40:112-120.
5. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007;21:2683-2710.
6. Doblas S, Saunders D, Kshirsagar P, et al. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radic Biol Med 2008;44:63-72.
7. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-372.
8. Folkerth RD. Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neurooncol 2000;50:165-172.
9. Korkolopoulou P, Patsouris E, Kavantzas N, et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002;28:57-66.
10. Kish PE, Blaivas M, Strawderman M, et al. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol 2001;53:243-257.
11. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998;36:91-102.
12. Valable S, Lemasson B, Farion R, et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 2008;21:1043-1056.
13. Koestner A, Swenberg JA, Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am J Pathol 1971;63:37-56.
14. Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 2002;310:257-270. (Pubitemid 35435769)
15. Sibenaller ZA, Etame AB, Ali MM, et al. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus 2005;19:E1-E9.
16. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993;53:5822-5827.
17. Szatmari T, Lumniczky K, Desaknai S, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 2006;97:546-553.
18. Cheng SY, Huang HJ, Nagane M, et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci U S A 1996;93:8502-8507.
19. Hensley K, Abdel-Moaty H, Hunter J, et al. Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation. J Neuroinflammation 2006;3:2-10.
20. von Kienlin M, Ziegler A, Le Fur Y, Rubin C, Decorps M, Remy C. 2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain. Magn Reson Med 2000;43:211-219. (Pubitemid 30075443)
21. Kobayashi N, Allen N, Clendenon NR, Ko LW. An improved rat brain-tumor model. J Neurosurg 1980;53:808-815.
22. RygaardK, Spang-Thomsen M.Quantitation and gompertzian analysis of tumor growth. Breast Cancer Res Treat 1997;46:303-312.
23. Demicheli R, Foroni R, Ingrosso A, Pratesi G, Soranzo C, Tortoreto M. An exponential-gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res 1989;49:6543-6546.
24. Johansson FK, Goransson H, Westermark B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 2005;24:3896-3905.
25. Schierling W, Troidl K, Mueller C, et al. Increased intravascular flow rate triggers cerebral arteriogenesis. J Cereb Blood Flow Metab 2009;29:726-737.
26. Seshadri M, Ciesielski MJ. MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas. J Cereb Blood Flow Metab 2009;29:1373-1382.
27. Lin CY, Lin MH, Cheung WM, Lin TN, Chen JH, Chang C. In vivo cerebromicrovasculatural visualization using 3D DeltaR2-based microscopy of magnetic resonance angiography (3DDeltaR2-mMRA). Neuroimage 2009;45:824-831.
28. Kitamura N, Araya R, Kudoh M, et al. Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency. PLoS One 2009;4:e5159.
29. Cheng CH, Kikuchi T, Chen YH, et al. Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res 2009;81:381-388.
30. Togbe D, de Sousa PL, Fauconnier M, et al. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One 2008;3:e2608.
31. Bullitt E, Wolthusen PA, Brubaker L, Lin W, Zeng D, Van Dyke T. Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice. AJNR Am J Neuroradiol 2006;27:612-619. (Pubitemid 44897786)
32. Barth RF, Moeschberger ML. Rat brain tumor models and the statistical evaluation of survival data in experimental neuro-oncology. In: Chiocca EA, Breakefield XO, editors. Gene therapy for neurological disorders and brain tumors. Totowa, NJ: Humana Press; 1997. p 313.
33. Peterson DL, Sheridan PJ, Brown WE, Jr. Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 1994;80:865-876.
34. Vaquero J, Coca S, Zurita M, et al. Synaptophysin expression in "ependymal tumors" induced by ethyl-nitrosourea in rats. Am J Pathol 1992;141:1037-1041.
35. Vince GH, Bendszus M, Schweitzer T, et al. Spontaneous regression of experimental gliomas - an immunohistochemical and MRI study of the C6 glioma spheroid implantation model. Exp Neurol 2004;190:478-485.
36. Asanuma T, Doblas S, Tesiram YA, et al. Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography. J Magn Reson Imaging 2008;28:574-587.
37. Acker T, Plate KH. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk. Cell Tissue Res 2003;314:145-155. (Pubitemid 37409920)
38. Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio- resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008;19:205-216.